Rabphilin 3A: A novel target for the treatment of levodopa-induced dyskinesias

Rabphilin 3A: A novel target for the treatment of levodopa-induced dyskinesias

N-methyl-d-aspartate receptor (NMDAR) subunit composition strictly commands receptor function and pharmacological responses. Changes in NMDAR subunit composition have been documented in brain disorders such as Parkinson's disease (PD) and levodopa (L-DOPA)-induced dyskinesias (LIDs), where an i...

Full description

Bibliographic Details
Main Authors: Jennifer Stanic, Manuela Mellone, Francesco Napolitano, Claudia Racca, Elisa Zianni, Daiana Minocci, Veronica Ghiglieri, Marie-Laure Thiolat, Qin Li, Annalisa Longhi, Arianna De Rosa, Barbara Picconi, Erwan Bezard, Paolo Calabresi, Monica Di Luca, Alessandro Usiello, Fabrizio Gardoni
Format: Article
Language:English
Published: Elsevier 2017-12-01
Series:Neurobiology of Disease
Subjects:
N-methyl-d-aspartate receptor
Levodopa-induced dyskinesias
Pharmacological target
Cell-permeable peptides
Online Access:http://www.sciencedirect.com/science/article/pii/S096999611730181X

Internet

http://www.sciencedirect.com/science/article/pii/S096999611730181X

Similar Items